Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine · generic available

Manganese chloride

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Manganese chloride used for?
The FDA-approved label (Manganese, Hospira, Inc., April 15, 2026) says: “Manganese 0.1 mg/mL (Manganese Chloride Injection, USP) is indicated for use in adult patients as a supplement to intravenous solutions given for TPN. Administration helps to maintain manganese serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Manganese chloride have a boxed warning?
No. None of the 2 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Manganese chloride?
No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
Has Manganese chloride been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Manganese chloride?
2 companies list prescription products of Manganese chloride in the FDA NDC Directory, including Hospira, Inc. and Fresenius Kabi USA, LLC.

What Manganese chloride is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

Manganese 0.1 mg/mL (Manganese Chloride Injection, USP) is indicated for use in adult patients as a supplement to intravenous solutions given for TPN. Administration helps to maintain manganese serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.

— FDA label: Manganese, Hospira, Inc., effective April 15, 2026. Read the full label on DailyMed →

The FDA has 2 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

0 of 2 FDA labels for this medicine have a boxed warning.

Forms and how it is given

Dosage formsInjection, solution
RouteIntravenous
Prescription products2 in the FDA NDC Directory

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
NDA018962
MANGANESE CHLORIDE IN PLASTIC CONTAINER
HospiraJune 26, 1986 11, latest December 18, 2023
2023: Labeling · 2014: Manufacturing (CMC) · 2004: Labeling

Generic approvals (1)

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

RxCUI (RxNorm)237521
SPL set ID of the quoted label6e979070-5035-4076-e09c-b52466be3c68
FDA labels (SPL)2
FDA applicationsNDA018962, 1 ANDA
Active ingredients (FDA)MANGANESE CHLORIDE

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Manganese, Hospira, Inc., effective April 15, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers